DTNBP1 and hepatocellular carcinoma: Taken together, these findings demonstrated that DTNBP1 is overexpressed in HCC patients and is further increased as the patient’s progress moves to a more lethal stage, indicating that DTNBP1 may serve as an oncogenic factor determining HCC progression.